BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 21576598)

  • 1. The Model for End-Stage Liver Disease score: an independent prognostic factor of mortality in injured cirrhotic patients.
    Inaba K; Barmparas G; Resnick S; Browder T; Chan LS; Lam L; Talving P; Demetriades D
    Arch Surg; 2011 Sep; 146(9):1074-8. PubMed ID: 21576598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model for end-stage liver disease (MELD) score as a useful prognostic marker in cirrhotic patients with infection.
    Khan R; Abid S; Jafri W; Awan S; Hamid S; Shah H; Pervez S
    J Coll Physicians Surg Pak; 2009 Nov; 19(11):694-8. PubMed ID: 19889264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of cirrhotic patients with blunt abdominal trauma: analysis of risk factor of postoperative death with the Model for End-Stage Liver Disease score.
    Lin BC; Fang JF; Wong YC; Hwang TL; Hsu YP
    Injury; 2012 Sep; 43(9):1457-61. PubMed ID: 21511254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver dysfunction by model for end-stage liver disease score improves mortality prediction in injured patients with cirrhosis.
    Corneille MG; Nicholson S; Richa J; Son C; Michalek J; Wolf SE; Stewart R
    J Trauma; 2011 Jul; 71(1):6-11. PubMed ID: 21818010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do chronic liver disease scoring systems predict outcomes in trauma patients with liver disease? A comparison of MELD and CTP.
    Seamon MJ; Franco MJ; Stawicki SP; Smith BP; Kulp H; Goldberg AJ; Santora TA; Gaughan JP
    J Trauma; 2010 Sep; 69(3):568-73. PubMed ID: 20838128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
    Giannini E; Botta F; Fumagalli A; Malfatti F; Testa E; Chiarbonello B; Polegato S; Bellotti M; Milazzo S; Borgonovo G; Testa R
    Liver Int; 2004 Oct; 24(5):465-70. PubMed ID: 15482344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The anaylsis of mortality rate according to CTP score and MELD score in patients with liver cirrhosis].
    Jeong EM; Hwang SG; Park HH; Park JH; Kim HT; Oh SW; Kho KH; Hong SP; Park PW; Rim GS; Kim SH
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):98-106. PubMed ID: 12824749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
    Lv XH; Liu HB; Wang Y; Wang BY; Song M; Sun MJ
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
    Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
    J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score.
    Huo TI; Lin HC; Lee FY; Hou MC; Lee PC; Wu JC; Chang FY; Lee SD
    Liver Int; 2006 Feb; 26(1):55-61. PubMed ID: 16420510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model.
    Sun QF; Ding JG; Xu DZ; Chen YP; Hong L; Ye ZY; Zheng MH; Fu RQ; Wu JG; Du QW; Chen W; Wang XF; Sheng JF
    J Viral Hepat; 2009 Jul; 16(7):464-70. PubMed ID: 19413694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cirrhotic patients in the medical intensive care unit: early prognosis and long-term survival.
    Das V; Boelle PY; Galbois A; Guidet B; Maury E; Carbonell N; Moreau R; Offenstadt G
    Crit Care Med; 2010 Nov; 38(11):2108-16. PubMed ID: 20802324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New scoring systems for severity outcome of liver cirrhosis and hepatocellular carcinoma: current issues concerning the Child-Turcotte-Pugh score and the Model of End-Stage Liver Disease (MELD) score].
    Lee DH; Son JH; Kim TW
    Taehan Kan Hakhoe Chi; 2003 Sep; 9(3):167-79. PubMed ID: 14515034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone.
    Ruf AE; Kremers WK; Chavez LL; Descalzi VI; Podesta LG; Villamil FG
    Liver Transpl; 2005 Mar; 11(3):336-43. PubMed ID: 15719386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of liver cirrhosis on outcomes in trauma patients: a prospective study.
    Talving P; Lustenberger T; Okoye OT; Lam L; Smith JA; Inaba K; Mohseni S; Chan L; Demetriades D
    J Trauma Acute Care Surg; 2013 Oct; 75(4):699-703. PubMed ID: 24064886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients.
    Farnsworth N; Fagan SP; Berger DH; Awad SS
    Am J Surg; 2004 Nov; 188(5):580-3. PubMed ID: 15546574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis.
    Cucchetti A; Ercolani G; Vivarelli M; Cescon M; Ravaioli M; La Barba G; Zanello M; Grazi GL; Pinna AD
    Liver Transpl; 2006 Jun; 12(6):966-71. PubMed ID: 16598792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis.
    Teh SH; Sheppard BC; Schwartz J; Orloff SL
    Am J Surg; 2008 May; 195(5):697-701. PubMed ID: 18367132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical usefulness of DeltaMELD to predict the survival of patients with liver cirrhosis].
    Eun SH; Kim YS; Jang JY; Cheon YG; Kim YS; Cho YD; Lee JS; Lee MS; Kim JH; Shim CS; Kim BS
    Korean J Hepatol; 2006 Dec; 12(4):530-8. PubMed ID: 17237631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
    Radha Krishna Y; Saraswat VA; Das K; Himanshu G; Yachha SK; Aggarwal R; Choudhuri G
    Liver Int; 2009 Mar; 29(3):392-8. PubMed ID: 19267864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.